Objectives: Several serum antibodies against gangliosides are diagnostically important, particularly in Guillain-Barré syndrome (GBS), Miller Fisher syndrome (MFS), and multifocal motor neuropathy ...

A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and limb events and mortality, researchers reported at the Society for Vascular ...

Reactivation of HSV-1 has been reported most frequently and is one of the most likely causes of the condition in adults. [9, 10] VZV reactivation can also cause acute peripheral facial paralysis ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

Medically reviewed by Andrew Greenberg, MD Peripheral vision is what you see beyond your direct line of sight. It helps provide a complete sense of your surroundings without moving your head. Jump to ...

Pediatr Infect Dis J. 2005;24(2):97-101. In conclusion, this study indicates that VZV reactivation is an important cause of acute peripheral facial paralysis in children, especially those 6-15 ...

Background: The purpose of this study was to determine if gabapentin, an anti-convulsant used for neuropathic pain, is effective in improving pain and symptoms due to chemotherapy-induced peripheral ...

Partner Therapeutics, Inc. (PTx) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of PTx's Marketing ...

Postural sway velocity as a screening tool in diabetic peripheral neuropathy represents a potential early marker of balance impairment and fall risk. The 2025 annual meeting of the Peripheral Nerve ...

While symptoms for some can be mild, others may report severe pain and loss of function. ︎ Diabetic peripheral neuropathy, which affects about 30% of diabetics, can cause numbness, tingling, or ...

Peripheral artery disease (PAD) is characterized by atherosclerosis of peripheral arteries and affects more than 230 million people worldwide, including 13% of adults over the age of 50. 1 PAD is ...